Life Science REIT is set to turn the majority of vacant spaces within its portfolio into labs, with locations occupied by non-life sciences firms also earmarked for repositioning. Simon Farnsworth, managing director at the REIT’s investment adviser Ironstone Asset Management,
Thank you for reading EG
Want to read more? Enjoy a story a week for FREE for one month.
Register
Find Out More